Keybanc analyst Aleksey Yefremov maintains Axalta Coating Sys (NYSE:AXTA) with a Overweight and raises the price target from $29 to $30.
United Therapeutics Q2 Adj. EPS $4.09 Beats $3.02 Estimate, Sales $446.50M Beat $378.75M Estimate
United Therapeutics (NASDAQ:UTHR) reported quarterly earnings of $4.09 per share which beat the analyst consensus estimate of $3.02 by 35.43 percent. This is a 11.14 percent increase over earnings of $3.68 per share from
